These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38406964)
1. DRUG USE RECOMMENDATIONS FOR COLISTIN INJECTION IN THE ADULT POPULATION. Amir M; Dodani SK; Nasim A; Babar ZU J Ayub Med Coll Abbottabad; 2023; 35(4):693-697. PubMed ID: 38406964 [TBL] [Abstract][Full Text] [Related]
2. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Tsuji BT; Pogue JM; Zavascki AP; Paul M; Daikos GL; Forrest A; Giacobbe DR; Viscoli C; Giamarellou H; Karaiskos I; Kaye D; Mouton JW; Tam VH; Thamlikitkul V; Wunderink RG; Li J; Nation RL; Kaye KS Pharmacotherapy; 2019 Jan; 39(1):10-39. PubMed ID: 30710469 [TBL] [Abstract][Full Text] [Related]
3. [Practical guideline for the use of colistin]. Dijkmans AC; Wilms EB; Kamerling IM; Birkhoff W; van Nieuwkoop C; Verbrugh HA; Touw DJ Ned Tijdschr Geneeskd; 2014; 158():A7445. PubMed ID: 25322351 [TBL] [Abstract][Full Text] [Related]
4. Dosing of colistin-back to basic PK/PD. Bergen PJ; Li J; Nation RL Curr Opin Pharmacol; 2011 Oct; 11(5):464-9. PubMed ID: 21835694 [TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
6. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Evans ME; Feola DJ; Rapp RP Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501 [TBL] [Abstract][Full Text] [Related]
7. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics. Kassamali Z; Jain R; Danziger LH Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655 [TBL] [Abstract][Full Text] [Related]
8. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Ardebili A; Izanloo A; Rastegar M Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511 [TBL] [Abstract][Full Text] [Related]
9. Rational use of intravenous polymyxin B and colistin: A review. Zakuan ZD; Suresh K Med J Malaysia; 2018 Oct; 73(5):351-359. PubMed ID: 30350826 [TBL] [Abstract][Full Text] [Related]
10. Colistin: understanding and applying recent pharmacokinetic advances. Ortwine JK; Kaye KS; Li J; Pogue JM Pharmacotherapy; 2015 Jan; 35(1):11-6. PubMed ID: 25187500 [TBL] [Abstract][Full Text] [Related]
11. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Lim LM; Ly N; Anderson D; Yang JC; Macander L; Jarkowski A; Forrest A; Bulitta JB; Tsuji BT Pharmacotherapy; 2010 Dec; 30(12):1279-91. PubMed ID: 21114395 [TBL] [Abstract][Full Text] [Related]
12. To B or not to B, that is the question: is it time to replace colistin with polymyxin B? Kassamali Z; Danziger L Pharmacotherapy; 2015 Jan; 35(1):17-21. PubMed ID: 25346395 [TBL] [Abstract][Full Text] [Related]
14. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis. Liu D; Zhang J; Liu HX; Zhu YG; Qu JM Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic Resistance Pattern Of Acinetobacter Baumannii Isolated From Bacteremia Patients In Pakistan. Jabeen F; Khan Z; Sohail M; Tahir A; Tipu I; Murtaza Saleem HG J Ayub Med Coll Abbottabad; 2022; 34(1):95-100. PubMed ID: 35466635 [TBL] [Abstract][Full Text] [Related]
16. Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). El-Sayed Ahmed MAE; Zhong LL; Shen C; Yang Y; Doi Y; Tian GB Emerg Microbes Infect; 2020 Dec; 9(1):868-885. PubMed ID: 32284036 [TBL] [Abstract][Full Text] [Related]
17. Global survey of polymyxin use: A call for international guidelines. Wertheim H; Van Nguyen K; Hara GL; Gelband H; Laxminarayan R; Mouton J; Cars O J Glob Antimicrob Resist; 2013 Sep; 1(3):131-134. PubMed ID: 24749079 [TBL] [Abstract][Full Text] [Related]
18. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Nation RL; Li J; Cars O; Couet W; Dudley MN; Kaye KS; Mouton JW; Paterson DL; Tam VH; Theuretzbacher U; Tsuji BT; Turnidge JD Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221 [TBL] [Abstract][Full Text] [Related]
19. Resurgence of colistin use. Sarkar S; DeSantis ER; Kuper J Am J Health Syst Pharm; 2007 Dec; 64(23):2462-6. PubMed ID: 18029951 [TBL] [Abstract][Full Text] [Related]
20. The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study. Benattar YD; Omar M; Zusman O; Yahav D; Zak-Doron Y; Altunin S; Elbaz M; Daitch V; Granot M; Leibovici L; Paul M Clin Infect Dis; 2016 Dec; 63(12):1605-1612. PubMed ID: 27794023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]